Reading Tip!
>To get to the fulltext easy, use the library proxy bookmarklet or activate our Pubmed url for the Get it! button!
Categories
- Acta Derm Venereol (8)
- Allergy (2)
- Am J Dermatopathol (1)
- Am J Kidney Dis (1)
- Anal Bioanal Chem (1)
- Anal Chem (1)
- Ann Med (1)
- Arch Dermatol (3)
- Arch Phys Med Rehabil (1)
- Arthritis Res Ther (1)
- Arthritis Rheum (1)
- Australas J Dermatol (1)
- BMC Proc (1)
- Br J Dermatol (50)
- Cell Tissue Res (1)
- Clin Exp Dermatol (2)
- Contact Dermatitis (51)
- Dermatol Clin (3)
- Dermatol Res Pract (1)
- Dermatol Surg (1)
- Disabil Rehabil (1)
- Discov Med (2)
- Drugs Aging (2)
- Eur J Dermatol (10)
- Eur J Immunol (1)
- Exp Dermatol (4)
- Front Immunol (1)
- Genes Immun (1)
- Genet Test Mol Biomarkers (1)
- Hum Mol Genet (1)
- Hum Mutat (1)
- Hum Pathol (1)
- Infect Immun (1)
- Inflamm Bowel Dis (1)
- Int J Dermatol (1)
- Int J Med Microbiol (1)
- Invest Ophthalmol Vis Sci (1)
- J Allergy Clin Immunol (3)
- J Am Acad Dermatol (10)
- J Clin Invest (1)
- J Clin Virol (1)
- J Cutan Pathol (3)
- J Dermatol Sci (2)
- J Dtsch Dermatol Ges (4)
- J Eur Acad Dermatol Venereol (9)
- J Hand Ther (1)
- J Immunol (1)
- J Invest Dermatol (20)
- J Med Genet (1)
- J Strength Cond Res (2)
- JAMA Dermatol (4)
- JNMA J Nepal Med Assoc (1)
- Lab Chip (1)
- Methods Mol Biol (1)
- Mol Vis (1)
- N Engl J Med (1)
- Ned Tijdschr Geneeskd (13)
- Ned Tijdschr Tandheelkd (1)
- Neth J Med (1)
- Occup Environ Med (1)
- Opt Lett (1)
- PLoS One (2)
- Qual Health Res (1)
- Regul Toxicol Pharmacol (2)
- Report (1)
- Sci Transl Med (1)
- Skin Res Technol (2)
- Trials (1)
Archives
- May 2022
- April 2022
- March 2022
- February 2022
- January 2022
- December 2021
- November 2021
- October 2021
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- January 2021
- December 2020
- November 2020
- October 2020
- September 2020
- August 2020
- July 2020
- June 2020
- May 2020
- April 2020
- March 2020
- February 2020
- December 2019
- October 2019
- September 2019
- July 2019
- May 2019
- February 2019
- January 2019
- December 2018
- November 2018
- October 2018
- August 2018
- April 2018
- February 2018
- January 2018
- July 2017
- June 2017
- March 2017
- February 2017
- August 2016
- July 2016
- April 2016
- March 2016
- February 2016
- January 2016
- December 2015
- November 2015
- October 2015
- September 2015
- August 2015
- June 2015
- May 2015
- April 2015
- March 2015
- February 2015
- January 2015
- December 2014
- November 2014
- October 2014
- September 2014
- August 2014
- July 2014
- June 2014
- April 2014
- March 2014
- February 2014
- November 2013
- September 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- August 2012
- July 2012
- June 2012
Contributors
Meta
Monthly Archives: July 2019
Responsiveness and interpretability of the Hand Eczema Severity Index (HECSI).
![]() |
Related Articles |
Responsiveness and interpretability of the Hand Eczema Severity Index (HECSI).
Br J Dermatol. 2019 Jul 01;:
Authors: Oosterhaven JAF, Schuttelaar MLA
Abstract
BACKGROUND: The Hand Eczema Severity Index (HECSI) is used to measure severity of hand eczema. It is unclear what HECSI scores mean and what is the minimally important change (MIC). Furthermore, responsiveness has not been studied.
OBJECTIVES: To study responsiveness and interpretability of the HECSI.
METHODS: Prospective study covering two time points; baseline and after 4-12 weeks. Responsiveness was assessed using a criterion approach with a ≥ 1 step improvement on the ‘Photographic guide for severity of hand eczema’ as anchor for important improvement. Interpretability of single scores was determined by defining severity bands based on agreement with the anchor. For change scores, smallest detectable change (SDC) was calculated in unchanged patients and MIC was obtained in changed patients using three methods: mean cut-off, receiver operating curve (ROC) and 95%-limit.
RESULTS: N=294 patients participated (N=160 males, mean age 44·9). HECSI scores improved/deteriorated in parallel with the anchor. The area under the ROC curve was 0·86 (95% confidence interval: 0·81-0·91). The final severity band for single scores had a κ-coefficient of agreement of 0·694: clear, 0; almost clear, 1-16; moderate, 17-37; severe, 38-116; very severe, ≥117. The SDC in N=93 unchanged patients was 40·3 points. The obtained MIC values were all smaller than the SDC.
CONCLUSIONS: The HECSI has good responsiveness. This study gives meaning to HECSI scores, which can be applied to clinical decision making and the design of clinical trials. We recommend that an improvement of 41 points on the HECSI is regarded as minimally measurable true change. This article is protected by copyright. All rights reserved.
PMID: 31260086 [PubMed – as supplied by publisher]
Posted in Br J Dermatol
Comments Off on Responsiveness and interpretability of the Hand Eczema Severity Index (HECSI).